Literature DB >> 18455191

Morphologic diagnosis of "vascular dementia" - a critical update.

Kurt A Jellinger1.   

Abstract

Vascular dementia/vascular cognitive impairment (VaD/VCI) is not a single entity, but a large group of conditions characterized by various clinical and morphological findings and variable pathophysiology. Clinical diagnostic criteria show moderate sensitivity (50-70%) and variable specificity (64-98%). Epidemiological studies are hampered by the lack of clear and validated diagnostic criteria, the complexity of brain pathologies, ethnic and geographic variations. In Western clinic-based series VaD/VCI is suggested in 8-15% of cognitively impaired aged subjects, with age-standardized incidence ratios 0.42-2.6 and clinical prevalence at age 70+ of 6-15/1000 person/year. Prevalence in autopsy series ranges from 0.03 to 58% (real mean 8-15% in Western series, 22-35% in Japan). Both prevalence and incidence increase with age. Neuropathology shows multifocal and/or diffuse lesions, ranging from lacunes and microinfarcts, white matter lesions, hippocampal sclerosis to multi-infarct encephalopathy, mixed cortico-subcortical and diffuse post-ischemic lesions. They result from systemic, cardiac, local large and small vessel disease. Pathogenesis is multifactorial and cognitive decline is commonly associated with small ischemic/vascular lesions, often involving subcortical and strategically important brain areas (thalamus, frontobasal, limbic system). Pathophysiology affects neuronal networks involved in cognition, behavior, execution and memory. Vascular lesions often coexist with Alzheimer disease (AD) and other lesions, multiple pathologies greatly increasing the odds of dementia; 25-80% of demented subjects show both AD and cerebrovascular lesions. While both factors by synergistic interaction contribute significantly to the risk of dementia, AD pathology is often less severe in the presence of vascular lesions. Due to the heterogeneity of cerebrovascular pathology and its causative factors, no validated neuropathologic criteria for VaD are currently available, and a large variability across laboratories still exists in morphologic examination procedures and techniques. Harmonization of neuropathologic procedures and evaluation criteria in future prospective clinico-pathologic studies are needed to validate diagnostic criteria for VaD and to clarify the impact of vascular lesions on cognition.

Entities:  

Mesh:

Year:  2008        PMID: 18455191     DOI: 10.1016/j.jns.2008.03.006

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  40 in total

Review 1.  Bringing prevention in geriatrics: evidences from cardiovascular medicine supporting the new challenge.

Authors:  Angelo Scuteri; Edward G Lakatta
Journal:  Exp Gerontol       Date:  2012-03-03       Impact factor: 4.032

Review 2.  The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia.

Authors:  Costantino Iadecola
Journal:  Acta Neuropathol       Date:  2010-07-11       Impact factor: 17.088

3.  Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology.

Authors:  Henrieta Scholtzova; Richard J Kascsak; Kristyn A Bates; Allal Boutajangout; Daniel J Kerr; Harry C Meeker; Pankaj D Mehta; Daryl S Spinner; Thomas Wisniewski
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

4.  Acupuncture as a multifunctional neuroprotective therapy ameliorates cognitive impairment in a rat model of vascular dementia: A quantitative iTRAQ proteomics study.

Authors:  Jing-Wen Yang; Xue-Rui Wang; Meng Zhang; Ling-Yong Xiao; Wen Zhu; Cai-Shuo Ji; Cun-Zhi Liu
Journal:  CNS Neurosci Ther       Date:  2018-10-02       Impact factor: 5.243

Review 5.  The impact of cerebrovascular aging on vascular cognitive impairment and dementia.

Authors:  Tuo Yang; Yang Sun; Zhengyu Lu; Rehana K Leak; Feng Zhang
Journal:  Ageing Res Rev       Date:  2016-09-28       Impact factor: 10.895

Review 6.  Vascular cognitive impairment.

Authors:  Muhammad U Farooq; Philip B Gorelick
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

7.  Association of CETP polymorphisms with the risk of vascular dementia and white matter lesions.

Authors:  H Qureischie; R Heun; J Popp; F Jessen; W Maier; S Schmitz; F Hentschel; P Kelemen; H Kölsch
Journal:  J Neural Transm (Vienna)       Date:  2009-01-28       Impact factor: 3.575

Review 8.  Vascular pathology in the aged human brain.

Authors:  Lea Tenenholz Grinberg; Dietmar Rudolf Thal
Journal:  Acta Neuropathol       Date:  2010-02-14       Impact factor: 17.088

9.  Pro: Can neuropathology really confirm the exact diagnosis?

Authors:  Margaret M Esiri
Journal:  Alzheimers Res Ther       Date:  2010-05-07       Impact factor: 6.982

10.  NADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia.

Authors:  Dong-Hee Choi; Kyoung-Hee Lee; Ji-Hye Kim; Ju-Ha Seo; Hahn Young Kim; Chan Young Shin; Jung-Soo Han; Seol-Heui Han; Yoon-Seong Kim; Jongmin Lee
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.